Mark Hirschey / Wikimedia CommonsBerkshire Hathaway Inc. (NYSE: BRK-B) (NYSE: BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings. Many changes had been made in the June quarter…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Advanced Micro Devices Inc. (NYSE: AMD) raised to Neutral from Sell at…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings showing that there have been some significant changes in the positions of the Berkshire…
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the…
Warren Buffett of Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) is often considered the greatest investor in modern times. Some of us think that his status should be one of “The greatest…
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block.…
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech…
Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was going to be acquired or not. Bristol-Myers…
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the price appears to be more finite. We have heard enough names around…
We have several shares of biotech stocks on the move, but frankly the news from th American Society of Clinical Oncology, or ASCO, looks a bit muted. So far these are the…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings for the Berkshire Hathaway empire. This cut off date is as of March 31,…
The energy sector saw a lot of activity from short sellers in April, but other stocks saw some action as well. We’ve already covered some of the bigger names here and some…
Sony (NYSE: SNE) said it would finally turn around is prospects and make money in the next year. Bumbling CEO Sir Howard Stringer is gone. Sony’s core problems are not. It is…
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the biggest public merger rumors out there. At least that is the belief of Wall…
Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer. In February Amylin turned down a $3.5 billion ($22/share) offer from Bristol-Meyers…
